AHA comments on the CMS' hospital outpatient prospective payment system and ambulatory surgical center payment system proposed rule for calendar year (CY) 2024.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
American Hospital Association opposes the Federal Trade Commission’s proposed amendments to the Hart-Scott-Rodino (HSR) form and instructions.
AHA's comment on the calendar year (CY) 2024 HH prospective payment system (PPS) proposed rule.
AHA comments on the CMS' proposed changes on how certain forms of noncomprehensive coverage, including short-term, limited-duration plans, can be marketed and sold.
AHA voices support of the GOLD Card Act of 2023 (H.R. 4968).
AHA's comments on Energy and Commerce Committee Chair Rodgers’ drug shortages discussion draft.
AHA provides feedback on CMS' Episode Based Payment request for information.
The IRA, through the transferability provisions under Section 6418 and, in particular, the elective direct pay provisions of Section 6417, has provided new opportunities for the healthcare sector to engage in important clean energy initiatives.
The Drug Shortage Prevention Act would require manufacturers to notify the Food and Drug Administration (FDA) of increased demand of covered drugs. The AHA believes the requirement that manufacturers notify the FDA of increased demand for critical drugs will be an integral tool for shoring up the supply chain.
Pharmaceutical shortages and supply chain failures can have a devastating impact on patients. The RAPID Reserve Act would establish a program to improve supply chain resiliency for critical generic drug products, ensuring adequate supply is available even in the event of a shortage.